Profound Medical Corp. (PROF) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Profound Medical Corp. (PROF) Bundle
Looking to evaluate the intrinsic value of Profound Medical Corp.? Our PROF DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your projections and enhance your investment strategies.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9 | 5.1 | 4.8 | 4.6 | 5.0 | 5.9 | 6.9 | 8.2 | 9.7 | 11.4 |
| Revenue Growth, % | 0 | 72.61 | -5.9 | -2.79 | 7.75 | 17.92 | 17.92 | 17.92 | 17.92 | 17.92 |
| EBITDA | -8.7 | -13.5 | -19.9 | -24.0 | -18.6 | -5.9 | -6.9 | -8.2 | -9.7 | -11.4 |
| EBITDA, % | -296.01 | -266.92 | -416.82 | -518.4 | -372.01 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | 1.4 | 1.4 | 1.6 | 1.4 | .8 | 1.9 | 2.2 | 2.6 | 3.0 | 3.6 |
| Depreciation, % | 47.59 | 28.24 | 34.28 | 31.26 | 15.92 | 31.46 | 31.46 | 31.46 | 31.46 | 31.46 |
| EBIT | -10.1 | -15.0 | -21.5 | -25.5 | -19.4 | -5.9 | -6.9 | -8.2 | -9.7 | -11.4 |
| EBIT, % | -343.6 | -295.17 | -451.1 | -549.66 | -387.93 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | 10.2 | 58.2 | 46.6 | 32.3 | 18.2 | 5.9 | 6.9 | 8.2 | 9.7 | 11.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.8 | 5.2 | 1.0 | 4.4 | 5.1 | 4.4 | 5.2 | 6.2 | 7.3 | 8.6 |
| Account Receivables, % | 61.16 | 101.74 | 20.54 | 94.96 | 101.24 | 75.33 | 75.33 | 75.33 | 75.33 | 75.33 |
| Inventories | 2.5 | 3.7 | 5.1 | 5.5 | 4.9 | 5.4 | 6.3 | 7.5 | 8.8 | 10.4 |
| Inventories, % | 86.19 | 72.99 | 107.86 | 118.86 | 97.08 | 91.25 | 91.25 | 91.25 | 91.25 | 91.25 |
| Accounts Payable | 2.1 | 2.3 | 2.2 | 1.4 | 2.3 | 2.8 | 3.3 | 3.9 | 4.6 | 5.5 |
| Accounts Payable, % | 71.56 | 46.3 | 46.27 | 30.43 | 45.59 | 48.03 | 48.03 | 48.03 | 48.03 | 48.03 |
| Capital Expenditure | -.1 | -.2 | -.4 | .0 | .0 | -.2 | -.2 | -.3 | -.3 | -.4 |
| Capital Expenditure, % | -4.52 | -4.79 | -8.63 | 0 | 0.000002705921 | -3.59 | -3.59 | -3.59 | -3.59 | -3.59 |
| Tax Rate, % | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 | 0.44604 |
| EBITAT | -10.2 | -15.0 | -21.6 | -25.7 | -19.3 | -5.9 | -6.9 | -8.2 | -9.7 | -11.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -11.2 | -18.1 | -17.8 | -28.9 | -17.6 | -3.6 | -6.3 | -7.4 | -8.7 | -10.3 |
| WACC, % | 8.49 | 8.49 | 8.49 | 8.49 | 8.48 | 8.49 | 8.49 | 8.49 | 8.49 | 8.49 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -27.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -10 | |||||||||
| Terminal Value | -161 | |||||||||
| Present Terminal Value | -107 | |||||||||
| Enterprise Value | -135 | |||||||||
| Net Debt | -13 | |||||||||
| Equity Value | -122 | |||||||||
| Diluted Shares Outstanding, MM | 21 | |||||||||
| Equity Value Per Share | -5.77 |
What You Will Get
- Comprehensive PROF Financials: Access to both historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Real-Time Calculations: Dynamic computation of intrinsic value and NPV.
- Scenario Analysis: Evaluate various scenarios to assess Profound Medical's future performance.
- User-Friendly Design: Crafted for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive PROF Data: Pre-loaded with Profound Medical Corp.'s historical financial metrics and future projections.
- Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital expenditures.
- Dynamic Valuation Framework: Instant updates to Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive Interface: Clean, organized, and tailored for both seasoned professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file containing Profound Medical Corp.'s (PROF) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures as needed.
- 3. View Results Instantly: The DCF model automatically calculates intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
- 5. Utilize with Assurance: Present professional valuation insights to bolster your decision-making process.
Why Choose Profound Medical Corp. (PROF)?
- Innovative Solutions: Cutting-edge technology designed to enhance patient care and outcomes.
- Proven Results: Clinical evidence supports the effectiveness of our treatments.
- Patient-Centric Approach: Focused on improving the quality of life for patients through personalized care.
- Expert Team: Our professionals are leaders in the field, ensuring high standards and expertise.
- Commitment to Research: Ongoing investment in research and development to stay at the forefront of medical advancements.
Who Should Use Profound Medical Corp. (PROF)?
- Healthcare Investors: Make informed investment choices with cutting-edge medical technology insights.
- Medical Analysts: Streamline your analysis with comprehensive data on innovative treatment solutions.
- Consultants: Easily modify presentations or reports to showcase the latest advancements in medical procedures.
- Healthcare Enthusiasts: Enhance your knowledge of medical innovations through case studies and real-world applications.
- Educators and Students: Utilize it as a hands-on resource in healthcare and medical technology courses.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations specific to Profound Medical Corp. (PROF).
- Real-World Data: Profound Medical’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for deeper insights into Profound Medical's performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to Profound Medical Corp. (PROF).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to Profound Medical Corp. (PROF).